Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

Pharmacogenomics - 1 Feb 2007

Arbouw Maurits E L, van Vugt Jeroen P P, Egberts Toine C G, Guchelaar Henk-Jan

Abstract excerpt

Pharmacotherapy is the mainstay in the treatment of Parkinson's disease and the armamentarium of drugs available for the therapy of this disease is still expanding. Anti-Parkinson's disease drugs are effective in reducing the physical symptoms, such as hypokinesia, bradykinesia, rigidity and tremor. However, there is a large interindividual variability in response to anti-Parkinson's disease drugs with respect to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Genetic Variation
Share to Parkinson Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Source

Identifiers

PMID: 17286539
DOI: 10.2217/14622416.8.2.159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.PMID 17286539Read ↗

Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Parkinson’s Disease Pharmacogenomics: New Findings and PerspectivesSemantic proximity Read ↗

Anti-Parkinson's disease drugs and pharmacogenetic considerationsSemantic proximity Read ↗

Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic StudiesSemantic proximity Read ↗

Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Semantic proximity Read ↗

Pharmacogenetics and levodopa induced motor complicationsSemantic proximity Read ↗

A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?Semantic proximity Read ↗

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Semantic proximity Read ↗

The role of pharmacogenomics in the personalization of Parkinson's disease treatment.Semantic proximity Read ↗

Precision medicine for Parkinson’s disease: The subtyping challengeSemantic proximity Read ↗

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.Semantic proximity Read ↗

[Pharmacogenetics in Parkinson's disease treatment].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.